**The UFC heavyweight title picture entering mid-2026 remains unsettled, with trader pricing reflecting Tom Aspinall’s prolonged absence and rapid emergence of new contenders.** Aspinall, the undisputed champion after Jon Jones’s 2025 retirement, suffered an eye injury in a no-contest against Ciryl Gane at UFC 321 in October 2025. Medical delays have pushed his return timeline into question, limiting his window for defenses before year-end and opening the door for others. Recent activity has reshaped rankings and sentiment. Josh Hokit delivered a high-volume upset over Curtis Blaydes at UFC 327 in April 2026, earning Fight of the Night honors and a quick booking against Derrick Lewis at the White House event. Tyrell Fortune, a wrestling standout, cracked the top 10 with a win over Marcin Tybura and continues climbing. Rizvan Kuniev, Ante Delija, and others have notched victories that keep the division in flux. This competitive bunching around 42–45% for the top three outcomes captures the division’s volatility: Aspinall retains the edge if cleared for even one defense, yet Hokit’s momentum and Fortune’s rapid ascent create realistic paths for an end-of-year change. The market prices the field as wide open given injury uncertainty and the pace of new talent integration.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoTom Aspinall 42%
Ciryl Gane 28%
Ante Delija 27.7%
Serghei Spivac 10.0%
$324,110 Vol.
$324,110 Vol.
Tom Aspinall
42%
Ciryl Gane
28%
Ante Delija
28%
Serghei Spivac
10%
Derrick Lewis
7%
Jailton Almeida
5%
Waldo Cortes Acosta
5%
Alexander Volkov
2%
Marcin Tybura
1%
Sergei Pavlovich
18%
Lutador C
24%
Lutador B
1%
Lutador A
23%
Curtis Blaydes
<1%
Tom Aspinall 42%
Ciryl Gane 28%
Ante Delija 27.7%
Serghei Spivac 10.0%
$324,110 Vol.
$324,110 Vol.
Tom Aspinall
42%
Ciryl Gane
28%
Ante Delija
28%
Serghei Spivac
10%
Derrick Lewis
7%
Jailton Almeida
5%
Waldo Cortes Acosta
5%
Alexander Volkov
2%
Marcin Tybura
1%
Sergei Pavlovich
18%
Lutador C
24%
Lutador B
1%
Lutador A
23%
Curtis Blaydes
<1%
Only official UFC division champions will count. Interim champions will not count.
If the relevant belt is vacant at this market’s check time, or there is otherwise no champion in the specified division, this market will resolve to “Other”.
The primary resolution source for this market will be official information from the UFC (https://www.ufc.com/athletes).
Mercado Aberto: Jan 4, 2026, 2:33 PM ET
Resolver
0x2F5e3684c...Only official UFC division champions will count. Interim champions will not count.
If the relevant belt is vacant at this market’s check time, or there is otherwise no champion in the specified division, this market will resolve to “Other”.
The primary resolution source for this market will be official information from the UFC (https://www.ufc.com/athletes).
Resolver
0x2F5e3684c...**The UFC heavyweight title picture entering mid-2026 remains unsettled, with trader pricing reflecting Tom Aspinall’s prolonged absence and rapid emergence of new contenders.** Aspinall, the undisputed champion after Jon Jones’s 2025 retirement, suffered an eye injury in a no-contest against Ciryl Gane at UFC 321 in October 2025. Medical delays have pushed his return timeline into question, limiting his window for defenses before year-end and opening the door for others. Recent activity has reshaped rankings and sentiment. Josh Hokit delivered a high-volume upset over Curtis Blaydes at UFC 327 in April 2026, earning Fight of the Night honors and a quick booking against Derrick Lewis at the White House event. Tyrell Fortune, a wrestling standout, cracked the top 10 with a win over Marcin Tybura and continues climbing. Rizvan Kuniev, Ante Delija, and others have notched victories that keep the division in flux. This competitive bunching around 42–45% for the top three outcomes captures the division’s volatility: Aspinall retains the edge if cleared for even one defense, yet Hokit’s momentum and Fortune’s rapid ascent create realistic paths for an end-of-year change. The market prices the field as wide open given injury uncertainty and the pace of new talent integration.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions